A community-based sample of 685 women, aged 45–59 years (mean 51 years) living in East Turkey, was recruited in this recently published, cross-sectional study by Timur and Sahin [1]. An information form that included questions on descriptive characteristics and lifestyle variables of cases, the Menopause-Specific Quality of Life Questionnaire, and the Beck Depression Inventory were administered to each woman in the sample. The data were collected through a personal interview with each woman at her home. The prevalence of depression symptoms among the perimenopausal and postmenopausal women was 41.8%. Of all the women, 23.2% were premenopausal and 56.9% were postmenopausal. Logistic regression analysis revealed that the development of depression symptoms was 1.8 times higher in the perimenopausal–postmenopausal period than in the premenopausal period, 3.6 times higher among those with an event history affecting life in a negative way, and 2.0 times higher among those with a body mass index of 25 kg/m[+]2[/+] or higher.
Author(s)
-
Tamer Erel
Department of Obstetrics & Gynecology, Cerrahpaşa School of Medicine, İstanbul University, Turkey
Citations
-
Timur S, Sahin NH. The prevalence of depression symptoms and influencing factors among perimenopausal and postmenopausal women. Menopause 2010;17:545-51.
http://www.ncbi.nlm.nih.gov/pubmed/20400922 -
Deveci SE, Aik Y, Dag DG, Tokdemir M, Gndoğdu C. The frequency of depression and menopause-related symptoms in postmenopausal women living in a province in Eastern Turkey, and the factors that affect depressive status. Med Sci Monit 2010;16:PH40-7.
http://www.ncbi.nlm.nih.gov/pubmed/20357730 -
Seritan AL, Iosif AM, Park JH, et al. Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center. Menopause 2010;17:410-15.
http://www.ncbi.nlm.nih.gov/pubmed/20216277 -
Somunkiran A, Erel CT, Demirci F, Senturk ML. The effect of tibolone versus 17β-estradiol on climacteric symptoms in women with surgical menopause: A randomized, cross-over study. Maturitas 2007;56:61-8.
http://www.ncbi.nlm.nih.gov/pubmed/16831525 -
Erel CT. Professional development in menopause, Turkey. Presented at the 8th European Congress on Menopause (EMAS), London, UK, May 1620, 2009.
